NEPHROS INC (NEPH) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US6406714005
NEPHROS INC financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 18.79 m USD |
| Gross profit | 11.63 m USD |
| Operating income | 1.15 m USD |
| EBIT | 1.21 m USD |
| Net income | 1.19 m USD |
| Diluted EPS – continuing operations | 0.11 USD |
Full history since 2001, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About NEPHROS INC
Nephros, Inc., a commercial-stage company, develops and sells water filtration solutions for medical and commercial applications in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in foodservice and hospitality, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water; reduce biofilm and scale build-up; and remove cysts, particulates, and lead from water systems. It markets its products to food service and hospitality sectors including quick-service restaurants, convenience stores, and restaurants. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.
More stocks
- U S GLOBAL INVESTORS INC (GROW)
- Wintec Co. Ltd (320000.KQ)
- InfraCom Group AB (INFRA.ST)
- Forward Industries, Inc. (FWDI)
- INTERPACE BIOSCIENCES, INC. (IDXG)
- High Roller Technologies, Inc. (ROLR)
- Sachem Capital Corp. (SACH)
- Vanguard Green Investment Ltd (VGES)
- HyOrc Corp (HYOR)
- Future FinTech Group Inc. (FTFT)
- PIXELWORKS, INC (PXLW)
- AUTOSCOPE TECHNOLOGIES CORP (AATC)
Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.